Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
perivascular epithelioid cell tumors (PEComa)
Biotech
Gilead's Immunomedics CMO exits to Aadi as it nears FDA decision
She got Trodelvy to the finish line and now Loretta Itri, M.D., hopes to get Aadi Bioscience's first drug to market.
Kyle LaHucik
Oct 25, 2021 9:26am
Celgene-backed Aadi in the driving seat with $23M Series A round
May 8, 2017 8:27am
